H.R. 3, the drug pricing bill, is not the path forward.
Brett Guthrie: “H.R. 3, the drug pricing bill, is not the path forward.”
Editor's note · Context
Guthrie argues against H.R. 3, claiming it jeopardizes innovation for neurodegenerative disease treatments.
Share
More from Brett Guthrie
If you look at what’s going on in local communities, people are just concerned. These large loads coming into their local community, what’s it gonna do to their rates … And so that I think it opens up the opportunities for data centers to…
“The reporting raises serious questions about the organization’s actions over the past decade.”
“It is unacceptable that AAU is failing to implement standard reforms to protect child athletes, and is misleading the public, parents, and athletes about preventative measures in place within AAU sports,”
Every instance of fraud we uncover represents money stolen from taxpayers and care taken away from the patients who depend on it most.





